INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $713 | +8.5% | 53,116 | -0.0% | 0.30% | +2.4% |
Q4 2022 | $657 | -99.9% | 53,132 | -7.4% | 0.29% | -22.1% |
Q3 2022 | $801,000 | +9.3% | 57,396 | -0.1% | 0.38% | +26.7% |
Q2 2022 | $733,000 | -27.6% | 57,482 | -7.6% | 0.30% | -20.0% |
Q1 2022 | $1,012,000 | +4.3% | 62,185 | +4.4% | 0.37% | +6.6% |
Q4 2021 | $970,000 | – | 59,556 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
CM Management, LLC | 45,000 | $668,000 | 0.50% |
EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |